TREM1 and atherosclerosis: Our investigations in an easy-to-make, low-maintenance and reproducible model, which is representative of the advanced stages of atherosclerosis in humans, showed that low ESS increased the expression of inflammatory molecules and matrix-degrading enzymes through the activation of TREM-1.